Patients with overt DIC (disseminated intravascular coagulation)

Patients with known active atherosclerotic disease, such as active coronary artery disease or recent stroke in the past 3 months

Central venous access device related thrombus in the last 3 months

Patients with allergy to activated recombinant human factor VII or any component of its preparation

Efficacy and Safety of Activated Recombinant Human Factor VII in Refractory Haemorrhagic Cystitis